MedStar Health Expands Obesity Treatment Options with Endoscopic Sleeve Gastroplasty
Event summary
- MedStar Health performed its first endoscopic sleeve gastroplasty (ESG) procedure on August 21, 2026, offering a nonsurgical weight-loss option.
- The 90-minute procedure, performed by Dr. Christopher You, reduces stomach size without incisions, allowing patients to return home the same day.
- ESG is designed for patients who may not qualify for or want traditional bariatric surgery, addressing a treatment gap in obesity management.
- A study in The Lancet found ESG patients lost an average of 14% of their body weight in one year and maintained the loss for two years.
- MedStar Franklin Square's Center for Bariatric Surgery is MBSAQIP®-accredited, meeting national standards for quality and safety.
The big picture
MedStar Health's introduction of ESG reflects a broader trend in healthcare toward minimally invasive, patient-centric treatments for obesity. With over one billion people affected by obesity worldwide, the procedure addresses a critical gap for patients who are not candidates for traditional surgery. The move aligns with industry shifts toward personalized medicine and evidence-based interventions, positioning MedStar Health as a leader in innovative obesity care.
What we're watching
- Adoption Pace
- How quickly MedStar Health will integrate ESG into its broader obesity treatment portfolio and whether other health systems follow suit.
- Patient Outcomes
- The long-term efficacy of ESG compared to traditional bariatric surgery and its impact on patient health metrics.
- Regulatory Dynamics
- Whether the procedure will face any regulatory hurdles as it becomes more widely adopted.
Related topics